Skip to content
Endless Frontier LabsEndless Frontier Labs
  • About
  • Tracks
    • Deep Tech
    • Life Sciences
    • Digital Tech
  • Startups
  • Mentors
  • News
Current News

Strand Therapeutics is awarded NIH SBIR contract to develop mRNA-based CAR-T immunotherapy for non-Hodgkin’s lymphoma

Posted on November 9, 2021November 9, 2021 by Nour Obeidallah
09
Nov
This entry was posted in Current News. Bookmark the permalink.
Nour Obeidallah

Kintsugi named in “5 Startups Shaping the Future of Health Care” list by Inc.
PhagoMed Biopharma GmbH acquired by BioNTech. The acquisition will accelerate the development of their synthetic lysin platform
Recent Posts
  • Polaris Genomics raises $1M in debt
  • David Zamarin, Founder of Detrapel and its industrial pillar Impermea Materials, shares the health and environmental risks of per- and polyfluorinated substances (PFAS) and Impermea Materials’ PFAS-free packaging solution
  • Imvaria announces data demonstrating their digital biomarker Fibresolve’s ability to assist in predictions of mortality in patients with interstitial lung disease (ILD)
  • Immunai shares positive interim Ph1 data with BCM for a GD2 CAR-NKT therapy for Neuroblastoma from their collaboration with Baylor College of Medicine
  • Cortina partners with TikTok’s Famous “Dermadoctor”, Dr. Muneeb Shah
Recent Comments

    ABOUT
    TRACKS
    STARTUPS
    MENTORS
    TEAM

    ELIZABETH ELTING
    FAQs
    NEWS
    DASHBOARD

    Copyright 2023 © Endless Frontier Labs | Privacy Policy
    • About
    • Tracks
      • Deep Tech
      • Life Sciences
      • Digital Tech
    • Startups
    • Mentors
    • Team
    • Elizabeth Elting Fund
    • News
    • Information Sessions